TYE-1014

N/A

Report date: 2024/01/16 17:48:04

Base Information

Drug NameTYE-1014
Drug Alias NameTYE-1014TYE1014Tye1014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitosis inhibitors
TargetsSomatostatin receptor 2
Therapy Area/IndicationsSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Tyercan Bio-pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Tyercan Bio-pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A